TINNET as the next step in tinnitus research: Towards evidence-based medicine

The Tinnitus Research Initiative (TRI) has come a long way to bring tinnitus research from several scientific fields together. The European funded TINNET, 'Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments', can be regarded as the next step. It aims at coordination and standardization in tinnitus research and the enlargement of an already existing database with results from clinical trials. This should lead to a statistically relevant basis for tinnitus research. It promises the opportunity of standardized processes to enable tailor-made assessment for individual patients.

“At the start of the TRI in 2006 as a private initiative, there was only little tinnitus research compared to the number of people suffering from it. This research was isolated and results remained within the separated domains of ENT, audiology, psychology, psychiatry, and etcetera”, Dr. Berthold Langguth, head of the tinnitus center of Regensburg University concludes. TRI had the vision to bring disciplines together and to share results and insights. “Back then”, Langguth remembers, “the general assumption and conclusion were: 'Tinnitus cannot be cured, so learn to live with it'. The people involved in TRI, however, shared the belief that tinnitus should be treatable in principle – for instance with brain stimulation– although this treatment nor any other treatment was not proven yet. Their motto was and still is: 'Together for a cure'.” Since then, a lot has been achieved. For many patients, the suffering from tinnitus has been reduced.

Evidence base

“But tinnitus still is a very heterogeneous illness. It is difficult to treat”, says Langguth, “treatment is for a large part still mainly pioneering, the domain of pilot studies.” As yet, there are no clearly evidence based treatment methods except cognitive behavioral therapy (CBT) – which comes in several forms. Langguth: “But this doesn't affect the tinnitus percept itself, CBT has the goal to facilitate coping with it. While this provides important relief in many cases, it is not yet the solution for every patient suffering from tinnitus. Apart from that, there are many, many approaches with different rationales. Hearing loss compensation, optionally combined with forms of auditory stimulation, is widely accepted, but large controlled studies demonstrating the efficacy of these approaches are needed. Various innovative forms of individualized auditory stimulation offer sounds or music in frequency areas in the neighborhood of the tinnitus frequency. These forms of individualized auditory stimulation can interact with the neuronal mechanisms that generate tinnitus and have shown promising results in pilot studies.” But there is still a lot unclear, Langguth emphasizes: “How large are the clinical effects? Which variant works best with which type(s) of patients? What can we expect from pharmacological treatment or magnetic and electric brain stimulation? Before these newly developed treatments can be implemented in clinical routine, a conclusive statistical basis from large studies would be needed.”

New knowledge

The TINNET initiative was initiated to change this. It has now been approved by the European Cooperation in Science and Technology (COST) Committee of Senior Officials, thus ensuring European funding. “With that, we get the opportunity to lift tinnitus research to the next level. We still largely depend on the outcomes of isolated trials with a couple of dozens of heterogeneous patients, which causes results to partly depend on group configuration. When data from similar trials from dozens of centers or more can henceforth be introduced in the database, this opens a lot of opportunities.” Once detailed data from many persons is gathered, it will allow us to derive new knowledge, says Langguth: “We could understand in more detail what forms of tinnitus do exist and what the differences between the various forms are. The goal would be to create a data-based expert system, which would provide guidance of which treatment has the best chances for success in a given patient: So hopefully in some years, we can ask the database what would be the recommendation for a 56 years old male, who suffers from a tonal tinnitus since a noise trauma two years ago, and the database would tell us, that a combination of drug X and auditory stimulation Y is the most promising first-line treatment for this individual.”

Dr. Berthold Langguth held a speech on the TINNET initiative during the 8th TRI international Conference from 10-13 March in Auckland, New Zealand. COST invites tinnitus researchers from as many European countries as possible to participate in the project.

Leendert van der Ent


Photo: Lasse Designen - Fotolia
Reminder: EUHA Congress call to papers deadline is no later than March 31, 2024
Reminder: EUHA Congress call to papers deadline is no later than March 31, 2024

 
 

RESEARCH AT CONFERENCES

© EUHA

The call to papers for the 68th International Congress of Hearing Aid Acousticians (EUHA) has a deadline of March 31, 2024.

Hearing aid sales dipped Q4 2023 in UK and ROI but year overall was "strong and promising"
Hearing aid sales dipped Q4 2023 in UK and ROI but year overall was

 
 

hearing market

© BIHIMA

Covid and post-Covid hearing instrument sales figures to the end of 2023 in the UK and Ireland have encouraged manufacturers. 2024 could confirm stable growth after spikes provoked by pandemic factors.

Cochlear implants: stigma and lack of information keeping use low among Spain's profoundly deaf
Cochlear implants: stigma and lack of information keeping use low among Spain's profoundly deaf

 

cochlear implants

©GAES      Cochlear implant technology continues to be underused in Spain despite its benefits for hearing.

Spain - 44% do not know what a cochlear implant is, yet more than 200,000 suffer profound hearing loss

Lars Rasmussen, new Chair of the WSA Board of Directors holds key university and life science positions in Denmark
Lars Rasmussen, new Chair of the WSA Board of Directors holds key university and life science positions in Denmark

 

Appointments

© WSA Lars Rasmussen

WS Audiology (WSA) has announced that Lars Rasmussen will take over as Chair of the WSA Board of Directors, succeeding Marco Gadola, effective March 1, 2024.

HIMSA schedules useful Noah ES webinar - sign up!
HIMSA schedules useful Noah ES webinar - sign up!

 
 
 

software

© HIMSA

Danish software producer HIMSA is running an informative webinar on Thursday February 29 to highlight features of its popular software Noah ES

AI AND HEARING AIDS - a balance to push possibilities
AI AND HEARING AIDS - a balance to push possibilities

 

Hearing aid technology

©Vink Fan - Jian Fan - iStock

Manufacturers reveal where they stand on artificial intelligence. Now we want to hear from professionals on how they see the pros and cons of AI in hearing instruments. Write to editor-in-chief Peter Wix with your views please. Tell us which companies you work with and how their AI is working out for you.

Training, recruitment, lack of unity,...the challenges facing audiology prefigure a tough immediate future for A FRACTURED PROFESSION
Training, recruitment, lack of unity,...the challenges facing audiology prefigure a tough immediate future for A FRACTURED PROFESSION

 

UK audiology

© PW “We should not be marking our own homework,” Claire Benton tells a packed BAA audience in Coventry last November.

The 2023 Conference of the British Academy of Audiology was given a soul-stirring launch last November when the group’s newly appointed Vice President, Claire Benton, laid bare the evidence of recent failings in NHS hearing care, carefully exposing her profession’s need for improved funding, appropriate training, and a tightening of discipline. Minutes after her galvanic Bamford Lecture, she spoke to Audiology News UK editor-in-chief Peter Wix about some of the crisis points facing hearing health practice.

 [ ... ]

Company Directory

New products

The expansion of Lumity: Phonak's flagship hearing aid fans out to all ages and loss levelsThe expansion of Lumity: Phonak's flagship hearing aid fans out to all ages and loss levels

 
 
 

 

© Phonak

Now available in the US, and hitting the UK and Ireland from March 4, Phonak's Lumity hearing aid technology has extended to encompass Audéo L-312, Naída L SP, and Sky L, M, and SP.

 [ ... ]

Intention-based personalisation - a perfect pitch from Demant's hearing aid brand?Intention-based personalisation - a perfect pitch from Demant's hearing aid brand?

 

hearing aids

© Oticon

Announcing its latest hearing aid as the world's first with 4D Sensor technology, Oticon has launched a new product: Intent. What is 4D Sensor technology and how does it relate to users' listening objectives?

 [ ... ]

An L shape? Widex is looking at hearing aids from a different - and interesting - angleAn L shape? Widex is looking at hearing aids from a different - and interesting - angle

 

hearing aids

© Widex

Widex has launched the Widex SmartRIC, a hearing aid featuring an innovative L-shaped design aimed at improving microphone angles to enhance directionality and speech targeting.

 [ ... ]